Quarterly report · Q2

Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥12.2bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥26.6bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥11.7bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥358m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥263m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥358m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥432m2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥249m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥358m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥249m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥221m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥271m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥144m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥229m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥154m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥13.5bnat 2024-03-31Cons.Assets
Total assets¥14.7bnat 2023-09-30Cons.Assets
Total assets¥15.3bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥7.7bnat 2024-03-31Cons.Liabilities
Total liabilities¥9.0bnat 2023-09-30Cons.Liabilities
Net assets / equity¥5.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥5.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥5.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.1bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥521m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥342m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥219m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥23m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥82m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥55m2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥100m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥202m2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥118m2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥112.462023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥71.452024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥138.372022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.312022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.682023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥111.782023-10-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥137.522022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥73.092022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio42.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio35.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31¥1m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue2023-10-01 → 2024-03-31¥211m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue external2023-10-01 → 2024-03-31¥211m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentsegment profit2023-10-01 → 2024-03-31¥7m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥372m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥372m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥31m
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥11.6bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥11.6bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥319m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥12.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥12.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥357m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31¥1m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue2022-10-01 → 2023-03-31¥205m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue external2022-10-01 → 2023-03-31¥205m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentsegment profit2022-10-01 → 2023-03-31¥4m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥362m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥362m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥39m
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥11.1bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥11.1bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥219m
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥11.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥11.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥262m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 500
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant877714000JPY
Noncurrent liabilitiesCurrentQuarterInstant921121000JPY
LiabilitiesPrior1YearInstant8969835000JPY
LiabilitiesCurrentQuarterInstant7653434000JPY
Capital stockPrior1YearInstant539369000JPY
Capital stockCurrentQuarterInstant540969000JPY
Capital surplusPrior1YearInstant498944000JPY
Capital surplusCurrentQuarterInstant500544000JPY
Retained earningsPrior1YearInstant4415850000JPY
Retained earningsCurrentQuarterInstant4538522000JPY
Treasury stockPrior1YearInstant-166000JPY
Treasury stockCurrentQuarterInstant-166000JPY
Shareholders equityPrior1YearInstant5453998000JPY
Shareholders equityCurrentQuarterInstant5579870000JPY
Valuation difference on available for sale securitiesPrior1YearInstant112497000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant132748000JPY
Valuation and translation adjustmentsPrior1YearInstant112497000JPY
Valuation and translation adjustmentsCurrentQuarterInstant132748000JPY
Non controlling interestsPrior1YearInstant157607000JPY
Non controlling interestsCurrentQuarterInstant161866000JPY
Net assetsPrior1YearInstant5724103000JPY
Net assetsCurrentQuarterInstant5874485000JPY
Liabilities and net assetsPrior1YearInstant14693938000JPY
Liabilities and net assetsCurrentQuarterInstant13527919000JPY
Net salesPrior1YTDDuration11662168000JPY
Net salesCurrentYTDDuration12216679000JPY
Cost of salesPrior1YTDDuration10236841000JPY
Cost of salesCurrentYTDDuration10631219000JPY
Gross profitPrior1YTDDuration1425327000JPY
Gross profitCurrentYTDDuration1585459000JPY
Selling general and administrative expensesPrior1YTDDuration1162136000JPY
Selling general and administrative expensesCurrentYTDDuration1227460000JPY
Operating incomePrior1YTDDuration263190000JPY
Operating incomeCurrentYTDDuration357998000JPY
Interest income noiPrior1YTDDuration52000JPY
Interest income noiCurrentYTDDuration44000JPY
Dividends income noiPrior1YTDDuration250000JPY
Dividends income noiCurrentYTDDuration300000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration896000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration-JPY
Subsidy income noi bountyPrior1YTDDuration712000JPY
Subsidy income noi bountyCurrentYTDDuration1005000JPY
Other noiPrior1YTDDuration1371000JPY
Other noiCurrentYTDDuration1309000JPY
Non operating incomePrior1YTDDuration3283000JPY
Non operating incomeCurrentYTDDuration2659000JPY
Interest expenses noePrior1YTDDuration481000JPY
Interest expenses noeCurrentYTDDuration-JPY
Guarantee commission noePrior1YTDDuration260000JPY
Guarantee commission noeCurrentYTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass